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Abstract
Metabolomic profiling can be used to study disease-induced changes in inflammatory bowel diseases (IBD). The aim of this
study was to investigate the difference in the metabolomic profile of males and females as they developed IBD. Using the IL-
10 gene-deficient mouse model of IBD and wild-type mice, urine at age 4, 6, 8, 12, 16, and 20 weeks was collected and
analyzed by nuclear magnetic resonance (NMR) spectroscopy. Multivariate data analysis was employed to assess differences
in metabolomic profiles that occurred as a consequence of IBD development and severity (at week 20). These changes were
contrasted to those that occurred as a consequence of gender. Our results demonstrate that both IL-10 gene-deficient and
wild-type mice exhibit gender-related changes in urinary metabolomic profile over time. Some male-female separating
metabolites are common to both IL-10 gene-deficient and control wild-type mice and, therefore, appear to be related
predominantly to gender maturation. In addition, we were able to identify gender-separating metabolites that are unique
for IL-10 gene-deficient and wild-type mice and, therefore, may be indicative of a gender-specific involvement in the
development and severity of the intestinal inflammation. The comparison of the gender-separating metabolomic profile
from IL-10 gene-deficient mice and wild-type mice during the development of IBD allowed us to identify changes in profile
patterns that appear to be imperative in the development of intestinal inflammation, but yet central to gender-related
differences in IBD development. The knowledge of metabolomic profile differences by gender and by disease severity has
potential clinical implications in the design of both biomarkers of disease as well as the development of optimal therapies.
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Introduction
Metabolic profiling can be used to study normal variations as
well as disease-induced changes in cellular and molecular
mechanisms. The comparison of metabolic profiles from various
bio-fluids is a powerful tool to investigate physiological or
pathophysiological changes under defined conditions, such as
gender and nutritional intake, at any given time point [1,2].
Furthermore, metabolomic analysis can identify metabolites with
potential importance as biomarkers in discriminating between
normal and pathological conditions.
Inflammatory bowel diseases (IBD), including Crohn’s disease
(CD) and ulcerative colitis (UC), are chronic, intestinal diseases of
unknown etiology [3]. Characteristics of these diseases are
uncontrolled immune responses to components of the endogenous
micro biota resulting in imbalances in cytokine production and
severe intestinal inflammation [4–6]. Recently, metabolomics has
been introduced to study pathophysiological differences in IBD in
humans [7–10] as well as in rodent models [11–16]. The
metabolomic changes accompanying the inflammatory response
led to distinct profiles that can be used to differentiate IBD from
non-IBD.
Treating women with IBD encounters different challenges than
treating men with IBD [17]. Furthermore, IBD-related gender
differences have been reported with regard to disease activity [18],
cardiovascular complications [19], urinary tract infections [20],
along with reduced deoxyribonuclease I serum activity levels,
which appears to have pathogenic consequences [21]. Conversely,
other studies have shown that gender does not appear to be a
major contributing factor in IBD [22]. The contradiction of these
studies helps to highlight our lack of understanding regarding the
role gender plays in IBD.
Gender differences have also been reported for other inflam-
matory disorders, including cardiovascular diseases, hepatocellular
carcinoma, diabetes, non-alcoholic fatty liver disease, osteoporosis,
and autoimmune diseases [23–27]. Largely, these differences are
attributed to gender-specific influences on immunological respons-
es [28,29]. In addition, gender-specific hormones themselves can
impact disease development and severity [30,31]. Gender differ-
ences are also well documented with regard to pharmacokinetics,
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manifested in drug toxicity and therapeutic responses, and
transport of endogenous and exogenous compounds in a variety
of organs [32]. Healthy male and female metabolism also differs
when assessed under similar conditions. This has been studied
primarily in regard to fat and carbohydrate metabolism in the
context of exercise and obesity [33,34]. For example, during
exercise, females oxidize proportionally more lipids and less
carbohydrate than males [35,36], likely as a consequence of higher
estrogen concentrations [37]. Basal fat oxidation is lower in
females than in males [33] resulting in proportionally higher body
fat, again, likely due to the effect of sex steroids and differences in
insulin resistance [34].
Gender differences have been investigated by RNA and
microarray analysis leading to the identification of distinct
metabolites. Recently, NMR metabolomics has been employed
to study male versus female differences [38], and analysis of urine
and plasma has resulted in clear gender separations in principal
component analysis (PCA) profiles [1].
To date, the metabolite differences generated by gender and the
resulting metabolomic profile have not been examined in IBD. A
detailed understanding of gender-related metabolite differences
will be important in the development of metabolomic biomarkers
for diagnosis and response to therapy. Using a mouse model of
IBD, we investigated differences in the metabolomic profile
between males and females as they progressed through onset of
intestinal inflammation, and compared these changes to healthy
control mice without intestinal inflammation.
Materials and Methods
Mice
IL-10 gene-deficient mice on 129Sv/Ev background and
control wild-type 129Sv/Ev mice were housed under specific
pathogen-free (SPF) conditions at the University of Alberta’s
animal facility. Mice were weaned at 4 weeks of age, which
coincided with the first urine collection time point. Urine was
collected thereafter at week 6, 8, 12, 16, and 20. Mice were
sacrificed at week 20 for histopathologic analysis and assessment of
cytokine secretion. Ten mice were used in each group.
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Canadian Council for Animal Care. The
protocol was approved by the Committee on Animal Ethics at the
University of Alberta.
Urine Collection in Metabolic Cages
For urine collection, mice were placed individually in metabolic
cages for 22 hours with access to water, but without food. Both,
fasting-induced stress responses as well as food intake can result in
metabolic changes. Controlling the amount and time of food
intake during the 22 hour urine collection period would have
posed an additional challenge, especially in light of the fact that we
were dealing with mice at various ages and gender and, thus,
varying body weights and dietary requirements. Therefore, we
opted for fasting during urine collection to keep external influences
at a minimum. Urine was funneled into vials prepared with
100 mL paraffin oil to avoid loss from evaporation. Funnels were
rinsed with 1.5 ml sterile water and an additional 500 mL solution
containing 0.02% sodium azide (NaN3) before samples were
harvested from collection vials and frozen at 280uC.
Sample Preparation and NMR Acquisition
For nuclear magnetic resonance (NMR) acquisition, samples
were thawed and debris was removed by filtering through a
thoroughly cleaned Nanosep Omega 3 K spin filter (Pal Corpo-
ration). An aliquot of 585 mL was transferred to a clean vial
containing 65 mL of 2,2-Dimethyl-2-silapentane-5-sulfonate-d6
sodium salt (DSS-d6) Chenomx internal standard (5.1436 mM
DSS-d6, 0.196% NaN3 w/v, 98% D20 v/v) purchased from
Chenomx Inc (Edmonton, AB, Canada). The pH was adjusted to
pH 6.7–6.8 using HCl and NaOH buffers and measured using an
Accumet XL 15 pH meter (Fisher Scientific, Canada). A 600 ml
sample was then loaded into an NMR tube and inserted into the
spectrometer.
NMR acquisition was performed on an Oxford 600 MHz
NMR spectrometer with a Varian VNMRS two-channel console
running VNMRJ software version 2.2C on a RHEL 4 host
computer. The spectrometer was equipped with an HX probe
with Z-axis gradients. Samples were run at a sweep width (sw) of
7225.43 Hz. The saturation frequency (sfrq), transmitter offset
(tof), and pulse width (pw) were all individually calibrated at the
start of each day. The tof typically ranged from 2213 to
2215 Hz, and the pw ranged from 6 to 8 ms. Shims were
optimized until an acceptable line-width value was obtained at
relative peak heights of: 50% (,1.0 Hz), 0.55% (,12.0 Hz), and
0.11% (,20.0 Hz). Finally, during post-processing, zero filling was
used to resolve the actual acquired data points to the next higher
factor of 2, and no weighting functions were applied.
We utilized the first increment of a 2D-1H,1H-NOESY pulse
sequence for the acquisition of 1H-NMR data and for suppressing
the solvent signal. Experiments used a 100 ms mixing time along
with a 990 ms pre-saturation (,80 Hz gammaB1). Spectra were
collected at 25uC through a total of 32 scans over a period of 3.5
minutes using a total recycle delay of 5 seconds (i.e., a 1-second
recovery delay/saturation and a 4-second acquisition).
Spectral Analysis
Samples were processed to fine-tune the phasing of spectra as
well as to eliminate the water peak and correct the baseline. The
line shape of the spectra was set to a width of 1.3 Hz. Spectral
analysis was done using Chenomx Inc NMR-suite software version
4.6. The chemical compound library was constructed for a pH
ranging between 6 and 8. 2,2-Dimethyl-2-silapentane-5-sulfonate-
d6 sodium salt (DSS-d6) was used as the internal standard. A total
of 56 metabolites were identified and quantified, not including the
DSS-d6 standard. After all spectra were analyzed, their metabolite
concentrations were exported from the program into an Excel file.
Statistical Analysis
The Excel files generated after spectral analysis were grouped
according to strain, gender, and age and multivariate statistical
analysis (principal Component Analysis (PCA) and partial least
squares – discriminant Analysis (PLS-DA)) was performed using
Simca P+ version 12.0.1 (Umetrics, Umea, Sweden).
Analysis of Inflammation
Colons were excised from mice euthanized at 20 weeks of age.
Tissues were cut longitudinally in half, washed in PBS, and fixed in
10% freshly prepared formalin. One half of each colon was then
embedded in paraffin, cut, and stained with hematoxylin and eosin
for light microscopy as previously described [39]. The slides were
scored in a blinded fashion (JD) according to a scheme ranging
from 0 (no injury) to 10 (maximal injury) as determined by four
parameters: mucosal ulceration, epithelial hyperplasia, lamina
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propria mononuclear and neutrophilic infiltration [39]. The other
half of the colon was weighed, placed in 1 mL RPMI culture
medium, and incubated at 37uC, 5% CO2 in humidified
atmosphere for 24 hours. IFNc in the supernatants of these
cultures were quantified by standard ELISA techniques using
commercial IFNc kits (R&D System Inc., Minneapolis, MN,
USA). In order to normalize IFNc release in individual cultures,
the concentration of this cytokine in 1 mL culture was computed
according to the weight of the tissue in this culture. Differences
between mean values derived from groups of male and female
mice were evaluated using t-tests or analysis of variance (Mann-
Whitney Rank Sum Test), where appropriate (SigmaStat, Jandel
Corporation, San Rafael, CA).
Results
Wild-type Male and Female Mice Cluster into Distinct
Groups According to their Metabolomic Profile
Using healthy wild-type mice, we investigated differences
between male and female mice using urine-based NMR
metabolomic analysis. PLS-DA derived from metabolite concen-
trations in mouse urine collected at 4, 6, 8, 12, 16, and 20 weeks of
age revealed that male and female mice separate into two distinct
metabolomic clusters with no overlap (Figure 1A).
Validation by random permutation revealed positive slopes for
both R2Y and Q2 with the original model having an R2Y of 0.965
and a Q2 of 0.944 (Figure 1B), indicating that separation observed
in the PLS-DA model in Figure 1A did not occur by chance. In
addition, no overlap was observed between metabolomic clusters
of male and female mice when PLS-DA plots were graphed
separately for the individual time points at 4, 6, 8, 12, 16, and 20
weeks of age. These graphs can be accessed as supplementary
material (Figures S 1, S 2, S 3, S 4, S 5, S 6 in File S1).
To investigate which metabolites were responsible for the
separation of male and female metabolomic clusters on the PLS-
DA plots, we employed coefficient graphs examining 56 selected
metabolites from the Chenomx Inc NMR-suite software. Metab-
olites with a variable importance in the projection (VIP) score of 1
and above were marked and identified in the graphs as those
important for female differentiation (positive coefficient score) and
male differentiation (negative coefficient score). This analysis
revealed a total of 20 metabolites that directed the separation of
wild-type females on the PLS-DA plots and 23 metabolites that
directed the separation of wild-type males on the PLS-DA plots
(Tables 1, 2).
We next examined which individual metabolites, contributing
to the separation, were unique or similar to each gender. Three
metabolites were unique to males at 4 weeks of age (uracil,
trigonelline, and dimethylamine). Two metabolites were unique to
females at 20 weeks of age (3-indoxylsulfate and phenylacetylgly-
cine) and two unique to males at 20 weeks of age (2-aminobutyrate
and hippurate). Metabolites that contributed to male and female
separation of the PLS-DA plot at each time point included 1-
methylnicotinamide, trimethylamine-N-oxide, and 3-methyl-2-
oxovalerate for females and succinate, trimethylamine, methyl-
amine, and N-isovaleroylglycine for males (Tables 1, 2). Other
metabolites contribute to the separation on more than one but not
on all time points, thus, creating a unique profile for male versus
female wild-type mice.
The Metabolomic Profile of IL-10 Gene-deficient Mice
Cluster into Distinct Groups Relative to both Severity of
IBD and Gender
Having shown that the metabolomic profiles separate due to
gender in healthy wild-type control mice, we next established
whether this gender-induced separation persisted, or was altered,
when mice developed IBD.
Mice with a genetically-engineered deletion of the anti-
inflammatory cytokine IL-10 develop an intestinal inflammation
beginning at 8 weeks of age and reaches its peak sustained activity
by 14 weeks of age [11,40]. IL-10 gene-deficient mice were
sacrificed at 20 weeks of age and characterized according to their
intestinal histopathologic injury score as well as to their
quantitative spontaneous inflammatory cytokine (IFNc) release
in cell culture. Intestinal inflammation was more severe in female
mice; manifested in a significantly higher histologic injury score
Figure 1. Metabolomic profiles of male and female wild-type mice. (A) Partial least squares-discriminant analysis (PLS-DA) of male (closed
triangle) versus female (open triangle) wild-type mice over all time points tested at weeks 4, 6, 8, 12, 16, and 20 demonstrate a gender separation in
two distinct clusters. (B) Validation of the PLS-DA plot using 20 random permutations of the data revealed an R2Y value of 0.965 and a Q2 value of
0.944, indicating that separation observed in the PLS-DA model in Figure 1A did not occur by chance. (R2Y = closed diamonds, Q2 = open diamonds).
doi:10.1371/journal.pone.0067654.g001
Table 1. Gender specific metabolites that contribute to the
separation of female wild-type control mice on the PLS-DA
plot at different experimental time points.
Metabolites Age (Weeks)
4 6 8 12 16 20
1. Formate + + + +
2. Guanidoacetate + +
3. Glycin + +
4. 1-Methylnicotinamide + + + + + +
5. Trimethylamin N-Oxide + + + + + +
6. 3-Methyl-2-Oxovalerate + + + + + +
7. Glutarate + + + +
8. Lactate + + + + +
9. Pyruvate + + + +
10. Glycolate + + + +
11. N-Carbamoyl-b-Alanine + + + +
12. 2-Oxoisocaproate + + + +
13. Acetate + +
14. Fucose + + +
15. Allantoin + +
16. Betaine +
17. cis-Aconitate + +
18. Mannose + +
19. 3-Indoxylsulfate +
20. Phenylacetylglycine +
Total number of metabolites 6 8 10 9 17 15
The plus sign (+) in a column indicates a metabolite that contributed to the
separation of the respective gender on the PLS-DA plot.
doi:10.1371/journal.pone.0067654.t001
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(Figure 2A), and significantly increased colonic IFNc secretion
(Figure 2B).
Similar to the results seen in the wild-type control mice
(Figure 1), PLS-DA analysis derived from metabolite concentra-
tions in IL-10 gene-deficient mouse urine collected at 4, 6, 8, 12,
16, and 20 weeks of age revealed that these male and female mice
also separated into 2 distinct metabolomic clusters at each time
point (Figure 3A). Validation by random permutation revealed
positive slopes for both R2Y and Q2 with the original model
having an R2Y of 0.858 and a Q2 of 0.813 (Figure 3B), indicating
that separation observed in the PLS-DA model in Figure 3A did
not occur by chance. Again, similar to wild-type control mice, no
overlap was observed between clusters of male and female mice
when PLS-DA plots were graphed separately for the individual
time points at 4, 6, 8, 12, 16, and 20 weeks of age (Figures S 7, S 8,
S 9, S 10, S 11, S 12 in File S2).
Analysis to investigate which metabolites were responsible for
the separation of IL-10 gene-deficient male and female metabo-
lomic clusters on the PLS-DA plots revealed a total of 19
metabolites that directed the separation of females on the PLS-DA
plots and 25 metabolites that directed the separation of males
(Tables 3, 4). Eight metabolites were unique to female Il-10 gene-
deficient mice at week 4 (fucose, carnitine, urea, isoleucine,
adipate, taurine, betaine, and o-acetylcarnitine). Two metabolites
were unique to males at week 4 (tyrosine, xylose) and 3 metabolites
were unique to males at week 20 (uracil, mannose, and N,N-
dimethylglycine). Two metabolites (1-methylnicotinamide and
lactate) were dominant in females at each time point. Only one
metabolite (succinate) was dominant in males at each time point
(Tables 3, 4).
Comparison of Wild-type to IL-10 Gene-deficient Mice
Metabolomic Profiles
To investigate the impact of IBD on the gender-specific
metabolomic profile identified above, we next compared metab-
olites from IL-10 gene-deficient mice with those from wild-type
control mice. While the number of individual metabolites (VIP
score .1) that determine the separation of males and females into
metabolomic clusters is similar in IL-10 gene-deficient mice and in
wild-type mice (19 female and 25 male in IL-10 gene-deficient
versus 20 female and 23 male in wild-type), the individual
metabolites and their distribution at varying ages differ substan-
tially.
In IL-10 gene-deficient mice, the gender-separating metabolites
at week 4 were mainly from metabolites that contributed to the
separation of females (i.e., female dominant) (12 out of 19) as
opposed to metabolites that contributed to the separation of males
(i.e., male dominant) (5 out of 25) (Tables 3, 4). This pattern was in
contrast to that seen in wild-type control mice where the gender-
separating metabolites at 4 weeks were male dominant metabolites
(13 out of 23) relative to female metabolites (6 out of 20) (Tables 1,
2). An opposite pattern emerges when animals at 16 and 20 weeks
of age are examined. The majority of gender-separating metab-
olites at these ages are female dominant in wild-type mice (17/20
and 15/20 at weeks 16 and 20, respectively for females compared
to 7/23 and 9/23, respectively for males) (Tables 1, 2); but male
dominant in Il-10 gene-deficient mice (12/25 and 13/25 at weeks
16 and 20, respectively for males compared to 6/19 and 7/19,
respectively for females) (Tables 3, 4).
A further comparison of the gender-separating metabolites in
IL-10 gene-deficient and wild-type control mice revealed metab-
olites that overlapped as well as metabolites that were unique for
gender separation across IL-10 gene-deficient and wild-type
mouse background (Table 5). Basically, the metabolites that
contribute to the separation of male from female can be divided
into four groups: a) those that are shared between IL-10 gene-
deficient and wild-type mice at one or more time points, b) those
that are common in IL-10 gene-deficient and wild-type mice but
never contribute to the gender separation at the same time point,
c) those that are unique for wild-type gender separation, and d)
those that are unique for IL-10 gene-deficient gender separation
(Table 5).
Metabolites that separate gender and are equally present in the
IL-10 gene-deficient and wild-type control mice are presumably
less affected by the underlying genetic difference in the two mouse
strains that ultimately leads to the development of IBD. This group
of metabolites include: succinate, taurine, valine, trimethylamine,
methylamine, and N-isovaleroylglycine for male-dominant metab-
olites and 1-methylnicotinamide, lactate, trimethylamine-N-oxide,
pyruvate, and glutarate for female-dominant metabolites (Table 5).
Conversely, metabolites that separate gender but are unique to the
wild-type control and IL-10 gene-deficient mice are presumably
more affected by the development of intestinal inflammation.
The Effect of age on Metabolomic Profiles
Finally, having shown that the metabolomic profile can separate
males from females in both IL-10 gene-deficient and wild-type
Table 2. Gender specific metabolites that contribute to the
separation of male wild-type control mice on the PLS-DA plot
at different experimental time points.
Metabolites Age (Weeks)




4. N,N-Dimethylglycine + + +
5. 2-Hydroxyisobutyrate + + +
6. Isoleucine + + +
7. Adipate + + + +
8. Citrate + +
9. Ethanolamine + + + +
10. Succinate + + + + + +
11. Trimethylamine + + + + + +
12. Methylamine + + + + + +
13. N-Isovaleroylglycine + + + + + +
14. Valine + + + + +
15. Taurine + + + + +
16. Butyrate + + + +







Total number of metabolites 13 13 12 14 7 9
The plus sign (+) in a column indicates a metabolite that contributed to the
separation of the respective gender on the PLS-DA plot.
doi:10.1371/journal.pone.0067654.t002
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control mice and that the individual metabolites responsible for
this separation are affected by both the genetics of the mice (i.e.,
IL-10 gene deficiency) and the development of intestinal
inflammation, we next examined the PLS-DA plots at each age
(Figure 4). At all 6 age points tested, metabolomic profiles from
wild-type males and females form tighter clusters than the
corresponding profiles of male and female IL-10 gene-deficient
mice.
Examining metabolomic separation of gender, at week 4 there is
an overlap of metabolomic profiles between male and female IL-
10 and between male and female wild-type (Figure 4A), consistent
with the low numbers of common gender separating metabolites at
this time point (Table 5). However, by week 6 and beyond
(Figures 4B–F), separation of the genders is complete and
pronounced, reflecting the higher number of common gender
separating metabolites (Table 5).
In contrast to the results for gender, examining the intestinally
inflamed IL-10 gene-deficient versus wild-type control mice, there
is overlap of the metabolomic profiles until weeks 16 and 20, the
time of maximal intestinal inflammation (Figures 4E, 4F). This
difference suggests that a significant effect is exerted by the
metabolites emanating as a consequence of the inflammation.
Discussion
This study demonstrates that the metabolomic profile of male
and female gender is manifested in unique metabolites and that
these profiles undergo gender-specific changes during the devel-
opment of intestinal inflammation.
Using urine-based NMR methodology combined with multi-
variate analysis we demonstrated that healthy wild-type control
male and female mice form distinct metabolomic clusters. A
kinetic analysis of the major metabolites involved in this gender
separation further revealed a change in the metabolomic profile as
the animals aged, up to 20 weeks. Similarly, the metabolomic
profiles of male and female IL-10 gene-deficient mice (an
Figure 2. Histologic injury score and IFNc immune response in male and female mice. (A) Histologic injury as determined by a scoring
system ranging from 0 (no injury) to 10 (maximal injury). (B) IFNc release in 24 hour colonic tissue culture as quantified by ELISA-based IFNc kits.
Graphs represent mean 6 SE for n = 10 mice per group. *p,0.05.
doi:10.1371/journal.pone.0067654.g002
Figure 3. Comparison of metabolomic profiles between male and female IL-10 gene-deficient mice. (A) Partial least squares-discriminant
analysis (PLS-DA) of male (closed circle) versus female (open circle) IL-10 gene-deficient mice over all time points tested at weeks 4, 6, 8, 12, 16, and 20
demonstrate a gender separation in two distinct clusters. (B) Validation of the PLS-DA plot using 20 random permutations of the data revealed an R2Y
value of 0.858 and a Q2 value of 0.813, indicating that separation observed in the PLS-DA model in Figure 3A did not occur by chance. (R2Y = closed
diamonds, Q2 = open diamonds.).
doi:10.1371/journal.pone.0067654.g003
Metabolomic Profiles in IBD
PLOS ONE | www.plosone.org 6 July 2013 | Volume 8 | Issue 7 | e67654
experimental model of IBD) separated into distinct clusters
according to gender. Nevertheless, the metabolites leading to
these gender-directed metabolomic profiles in the IL-10 gene-
deficient mice differ from those identified for the wild-type control
mice, even at an age when there is no gastrointestinal inflamma-
tion (i.e., 4, 6 and 8 weeks) [39], implying an important role of
genetics to the metabolomic profile. This is further supported by
the differences observed in previous findings demonstrating
increased pro-inflammatory cytokine release in young IL-10
gene-deficient mice before identifiable histopathologic injury [39].
In order to confirm disease states for each group of mice, colons
were excised and histology was performed on each mouse at the
end of the urine collection time periods (wk 20). Histology scores
ranged from 0 (no injury) to 10 (maximal injury). Histology scores
for the IL-10 gene-deficient mice were higher than those found at
base level for the wild-type mice (Figure 2A) regardless of gender.
A comparative analysis of the metabolites responsible for the
different metabolomic profiles in IL-10 gene-deficient and wild-
type control mice identified common metabolites that are shared
between the two strains and, therefore, appear to contribute to
gender differentiation independent of IBD or the IL-10 gene
deficiency. Metabolites that separate male gender in both IL-10
gene-deficient and wild-type mice include the amino acids valine
and taurine, succinate (a component of the citric acid cycle), as
well as methylamine, trimethylamine, and N-isovaleroylglycine (a
component of fatty acid metabolism). Metabolites that separate
female gender in both IL-10 gene-deficient and wild-type mice
include primarily oxidation products of metabolic intermediates
such as lactate, pyruvate, glutarate, and trimethylamine-N-oxide
in addition to 1-methylnicotinamide.
Unlike the common metabolites that determine gender separa-
tion over a wide range of ages, we have identified unique
metabolites that play a role in gender separation at one or only a
few selected ages in relation to the development of IBD and
gastrointestinal inflammation. We propose that these unique
metabolites are candidate biomarkers for the development of
intestinal inflammation. Unique metabolites are not universally
identified at each age point and are frequently present in both
females and males, particularly those involved in gender separa-
tion of IL-10 gene-deficient mice. For example carnitine, an amino
acid with a major role in fatty acid metabolism, is a female-
dominant metabolite in IL-10 gene-deficient mice at week 4 before
the histopathologic onset of disease and a male dominant
metabolite at week 16 when IBD is established in these mice
[11]. Hippurate, a metabolite that has been previously associated
with intestinal inflammation in humans, appears as a male-
dominant metabolite at week 20 in wild-type mice and as a female-
dominant metabolite at the start of pathophysiological inflamma-
tion at weeks 6 and 8 in IL-10 gene-deficient mice [9,41].
Table 3. Gender specific metabolites that contribute to the
separation of female IL-10 gene-deficient mice on the PLS-DA
plot at different experimental time points.
Metabolites Age (Weeks)









9. 1-Methylnicotinamide + + + + + +
10. Lactate + + + + + +
11. cis-Aconitate + + + +
12. Pyruvate + + + + +
13. Hippurate + +
14. Trimethylamine N-Oxide + + + +
15. Glutarate + + + + +




Total number of metabolites 12 7 7 7 6 7
The plus sign (+) in a column indicates a metabolite that contributed to the
separation of the respective gender on the PLS-DA plot.
doi:10.1371/journal.pone.0067654.t003
Table 4. Gender specific metabolites that contribute to the
separation of male IL-10 gene-deficient mice on the PLS-DA
plot at different experimental time points.
Metabolites Age (Weeks)
4 6 8 12 16 20
1. Tyrosine +
2. Xylose +
3. Ethanolamine + +
4. Succinate + + + + + +
5. Asparagine + + + +
6. 2-oxoisocaproate +
7. Betaine +
8. Pyro-glutamate + + +
9. Creatine + + + +
10. Valine + + + +
11. Trimethylamine + + + + +
12. N-Isovaleroylglycine + + + + +
13. Taurine + + + + +
14. Methylamine + + + + +
15. Isoleucine + + +
16. 2-Aminobutyrate + +
17. Butyrate + + +
18. 3-Hydroxybutyrate +
19. Adipate +






Total number of metabolites 5 13 10 12 12 13
The plus sign (+) in a column indicates a metabolite that contributed to the
separation of the respective gender on the PLS-DA plot.
doi:10.1371/journal.pone.0067654.t004
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Mannose, a carbohydrate involved in cellular recognition
processes [42], is involved in gender-separation as a male-
dominant metabolite at week 20 in IL-10 gene-deficient mice
with IBD and as a female-dominant metabolite at the same time
point in wild-type mice. These unique metabolites may also play a
role in the observed differences in disease severity observed




separation of males on
the PLS-DA plot Age (Weeks)
Metabolites that
contribute to separation
of females on the PLS-DA
plot Age (Weeks)
4 6 8 12 16 20 4 6 8 12 16 20
Metabolites Common to Wild-Type (a) And IL-10 Gene-Deficient (b) Mice
Succinate ab ab ab ab ab ab 1-Methylnicotinamide ab ab ab ab ab ab
Taurine ab ab ab ab ab Lactate b ab ab ab ab ab
Valine ab ab ab ab ab Trimethylamine N-oxide b ab ab ab b ab
Trimethylamine a ab ab ab ab ab Pyruvate b ab ab b ab ab
Methylamine a ab ab ab ab ab Glutarate ab ab ab ab B
N-Isovaleroylglycine a ab ab ab ab ab N-Carbomoyl-b-alanine ab ab a ab
Ethanolamine ab ab a a 3-Methyl-2-Oxovalerate a a a ab a a
Butyrate a ab ab b a Glycolate a a ab a
Creatine ab ab b b cis-Aconitate b b b a ab
Isoleucine a ab a b b
Adipate a a a ab
Pyroglutamate b b ab
3-Hydroxybutyrate ab
Metabolites Common But At Different Time Points In Wild-Type (a) And IL-10 Gene-Deficient (b) Mice
N,N-Dimethylglycine a a a b Fucose b a a a
Uracil a b Betaine b a
2-Aminobutyrate b b a
Metabolites Unique To Wild-Type (a) Mice
Trigonelline a Guanidoacetate a a
Dimethylamine a Formate a a a a
2-Hydroxyisobutyrate a a a Glycin a a
citrate a a 2-Oxoisocaproate a a a a
trans-Aconitate a Acetate a a
Methanol a Allantoin a a
Hippurate a Mannose a a
Phenylacetylglycine a
3-Indoxysulfate a
Metabolites Unique To IL-10 Gene-Deficient (b) Mice
Tyrosine b Urea b
Xylose b O-Acetylcarnitine b
Asparagine b b b b Taurine b
2-Oxoisocaproate b Isoleucine b
Betaine b Adipate b
Malonate b b b Carnitine b
Carnitine b Hippurate b b
Glucose b Xylose b
Mannose b
Total Common 2 9 8 10 6 6 Total Common 1 5 6 6 5 6
Total Wild-Type 11 4 4 4 1 3 Total Wild-Type 4 3 4 3 11 9
Total IL-10 Gene-Deficient 3 4 2 3 6 7 Total IL-10 Gene-Deficient 12 2 2 1 2 1
doi:10.1371/journal.pone.0067654.t005
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between male and female mice in the IL-10 gene-deficient group.
This is consistent with the analysis by Mittelstrass et al. which also
suggested that gender can lead to gender specific metabotypes
[43].
In comparing the metabolites responsible for the metabolomic
profile of gender in healthy IL-10 gene-deficient and wild-type
control mice over the time frame of IBD development, our study
revealed a different pattern in clustering between males and
females depending on the pattern of common versus unique
metabolites among male- and female-dominant compounds. In
this regard, cluster separation is weak at week 4 with very few
common metabolites (Figure 4A, Table 5). An increase in
metabolites that are common for gender differentiation in both
Figure 4. Comparison of metabolomic profiles between male and female IL-10 gene-deficient and wild-type mice. Metabolomic
analysis comparing groups of female wild-type (open triangle), male wild-type (closed triangle), female IL-10 gene-deficient (open circles), and male
IL-10 gene-deficient (closed circles) mice. PLS-DA analysis from 10 mice per group are shown at weeks 4 (A), 6 (B), 8 (C), 12 (D), 16 (E), and 20 (F).
doi:10.1371/journal.pone.0067654.g004
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strains leads to a separation of male and female clusters by week 6
(Figure 4B).
Over the time frame the intestinal inflammation develops, from
8 to 16 weeks, there are more common metabolites that define
male gender in both IL-10 gene-deficient and wild-type controls
mice than common metabolites that define female gender. Thus it
appears that for males, gender influences the metabolites to a
greater extent than does the animal’s genetic profile or the
intestinal inflammation. In contrast, the lower number of common
metabolites that define female gender suggests that in females, the
animal’s genetic profile and intestinal inflammation plays a larger
role in the metabolomic profile.
In this study, using urine-based NMR technology, we demon-
strated that metabolomic profiles, in a genetically-induced model
of IBD, are gender, age and disease specific. Comparison of
metabolite patterns computed from the analysis of male and
female, and IL-10 gene-deficient and wild-type control mice,
revealed dependent and independent changes in metabolites that
result in distinctive metabolomic profiles that are then further
impacted by the development of intestinal inflammation. The
knowledge of metabolomic profile differences by gender and by
disease states has potential clinical implications in the design of
both biomarkers of disease as well as the development of optimal
therapies.
Supporting Information
File S1 Figures S 1–S 6. Partial least squares-discriminant
analysis (PLS-DA) of male (closed triangle) versus female (open
triangle) wild-type mice at each individual time point tested (weeks
4, 6, 8, 12, 16, and 20) demonstrate a gender separation in two
distinct clusters on each plot.
(TIFF)
File S2 Figures S 7–S 12. Partial least squares-discriminant
analysis (PLS-DA) of male (closed circle) versus female (open circle)
IL-10 gene-deficient mice at each individual time point tested
(weeks 4, 6, 8, 12, 16, and 20) demonstrate a gender separation in
two distinct clusters on each plot.
(TIFF)
Acknowledgments
This study represents a portion of Victor Tso’s Masters in Experimental
Medicine thesis. Special acknowledgment is given to the team in NANUC
(Dr. Ryan Mckay and Deryck Webb) for assistance with the NMR
instrumentation and Shana Regush, Kathrine Rankin, and Hao Fu for
their assistance in the metabolomics process and analysis.
Author Contributions
Conceived and designed the experiments: VKT BCS RNF. Performed the
experiments: VKT RRF TAC BCS JD. Analyzed the data: VKT BCS
RNF. Contributed reagents/materials/analysis tools: TAC JD CMS RNF.
Wrote the paper: VKT BCS RNF.
References
1. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E (2005) NMR-
based metabonomic approaches for evaluating physiological influences on
biofluid composition. NMR Biomed 18: 143–162.
2. Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK (2004)
Metabonomics technologies and their applications in physiological monitoring,
drug safety assessment and disease diagnosis. Biomarkers 9: 1–31.
3. Bamias G, Cominelli F (2007) Immunopathogenesis of inflammatory bowel
disease: current concepts. Curr Opin Gastroenterol 23: 365–369.
4. Sartor RB (1997) Review article: Role of the enteric microflora in the
pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther
11 Suppl 3: 17–22; discussion 22-13.
5. Sherman MA, Kalman D (2004) Initiation and resolution of mucosal
inflammation. Immunol Res 29: 241–252.
6. Chichlowski M, Hale LP (2008) Bacterial-mucosal interactions in inflammatory
bowel disease: an alliance gone bad. Am J Physiol Gastrointest Liver Physiol
295: G1139–1149.
7. Marchesi JR, Holmes E, Khan F, Kochhar S, Scanlan P, et al. (2007) Rapid and
noninvasive metabonomic characterization of inflammatory bowel disease.
J Proteome Res 6: 546–551.
8. Bjerrum JT, Nielsen OH, Hao F, Tang H, Nicholson JK, et al. (2010)
Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and
insight into the pathophysiology. J Proteome Res 9: 954–962.
9. Williams HR, Cox IJ, Walker DG, Cobbold JF, Taylor-Robinson SD, et al.
(2010) Differences in gut microbial metabolism are responsible for reduced
hippurate synthesis in Crohn’s disease. BMC Gastroenterol 10: 108.
10. Zelinkova Z, Bultman E, Vogelaar L, Bouziane C, Kuipers EJ, et al. (2012) Sex-
dimorphic adverse drug reactions to immune suppressive agents in inflammatory
bowel disease. World J Gastroenterol 18: 6967–6973.
11. Murdoch TB, Fu H, MacFarlane S, Sydora BC, Fedorak RN, et al. (2008)
Urinary metabolic profiles of inflammatory bowel disease in interleukin-10 gene-
deficient mice. Anal Chem 80: 5524–5531.
12. Martin FP, Rezzi S, Philippe D, Tornier L, Messlik A, et al. (2009) Metabolic
assessment of gradual development of moderate experimental colitis in IL-10
deficient mice. J Proteome Res 8: 2376–2387.
13. Chen C, Shah YM, Morimura K, Krausz KW, Miyazaki M, et al. (2008)
Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation
exacerbates inflammation and acute colitis. Cell Metab 7: 135–147.
14. Schicho R, Nazyrova A, Shaykhutdinov R, Duggan G, Vogel HJ, et al. (2010)
Quantitative metabolomic profiling of serum and urine in DSS-induced
ulcerative colitis of mice by (1)H NMR spectroscopy. J Proteome Res 9:
6265–6273.
15. Otter D, Cao M, Lin HM, Fraser K, Edmunds S, et al. (2011) Identification of
urinary biomarkers of colon inflammation in IL102/2 mice using Short-
Column LCMS metabolomics. J Biomed Biotechnol 2011: 974701.
16. Qiao Q, Li T, Sun J, Liu X, Ren J, et al. (2011) Metabolomic analysis of normal
(C57BL/6J, 129S1/SvImJ) mice by gas chromatography-mass spectrometry:
detection of strain and gender differences. Talanta 85: 718–724.
17. Moleski SM, Choudhary C (2011) Special considerations for women with IBD.
Gastroenterol Clin North Am 40: 387–398, viii-ix.
18. Blumenstein I, Herrmann E, Filmann N, Zosel C, Tacke W, et al. (2011) Female
patients suffering from inflammatory bowel diseases are treated less frequently
with immunosuppressive medication and have a higher disease activity: a
subgroup analysis of a large multi-centre, prospective, internet-based study.
J Crohns Colitis 5: 203–210.
19. Sridhar AR, Parasa S, Navaneethan U, Crowell MD, Olden K (2011)
Comprehensive study of cardiovascular morbidity in hospitalized inflammatory
bowel disease patients. J Crohns Colitis 5: 287–294.
20. Peyrin-Biroulet L, Pillot C, Oussalah A, Billioud V, Aissa N, et al. Urinary tract
infections in hospitalized inflammatory bowel disease patients: A 10-year
experience. Inflamm Bowel Dis.
21. Malickova K, Duricova D, Bortlik M, Hruskova Z, Svobodova B, et al. (2011)
Impaired deoxyribonuclease I activity in patients with inflammatory bowel
diseases. Autoimmune Dis 2011: 945861.
22. Lee GJ, Kappelman MD, Boyle B, Colletti RB, King E, et al. (2012) Role of sex
in the treatment and clinical outcomes of pediatric patients with inflammatory
bowel disease. J Pediatr Gastroenterol Nutr 55: 701–706.
23. Fernandes MT, Ferraro AA, de Azevedo RA, Fagundes Neto U (2010)
Metabolic differences between male and female adolescents with non-alcoholic
fatty liver disease, as detected by ultrasound. Acta Paediatr 99: 1218–1223.
24. McCombe PA, Greer JM, Mackay IR (2009) Sexual dimorphism in
autoimmune disease. Curr Mol Med 9: 1058–1079.
25. Zandman-Goddard G, Peeva E, Shoenfeld Y (2007) Gender and autoimmunity.
Autoimmun Rev 6: 366–372.
26. Gleicher N, Barad DH (2007) Gender as risk factor for autoimmune diseases.
J Autoimmun 28: 1–6.
27. Ghazeeri G, Abdullah L, Abbas O (2011) Immunological differences in women
compared with men: overview and contributing factors. Am J Reprod Immunol
66: 163–169.
28. Duma D, Collins JB, Chou JW, Cidlowski JA (2010) Sexually dimorphic actions
of glucocorticoids provide a link to inflammatory diseases with gender differences
in prevalence. Sci Signal 3: ra74.
29. Alvarado CM, Diaz JA, Hawley AE, Wrobleski SK, Sigler RE, et al. (2011) Male
mice have increased thrombotic potential: sex differences in a mouse model of
venous thrombosis. Thromb Res 127: 478–486.
30. Chrousos GP (2010) Stress and sex versus immunity and inflammation. Sci
Signal 3: pe36.
31. Looijer-van Langen M, Hotte N, Dieleman LA, Albert E, Mulder C, et al. (2011)
Estrogen receptor-beta signaling modulates epithelial barrier function.
Am J Physiol Gastrointest Liver Physiol 300: G621–626.
Metabolomic Profiles in IBD
PLOS ONE | www.plosone.org 10 July 2013 | Volume 8 | Issue 7 | e67654
32. Morris ME, Lee HJ, Predko LM (2003) Gender differences in the membrane
transport of endogenous and exogenous compounds. Pharmacol Rev 55: 229–
240.
33. Blaak E (2001) Gender differences in fat metabolism. Curr Opin Clin Nutr
Metab Care 4: 499–502.
34. Wu BN, O’Sullivan AJ (2011) Sex differences in energy metabolism need to be
considered with lifestyle modifications in humans. J Nutr Metab 2011: 391809.
35. Tarnopolsky MA (2000) Gender differences in metabolism; nutrition and
supplements. J Sci Med Sport 3: 287–298.
36. Tarnopolsky MA, Ruby BC (2001) Sex differences in carbohydrate metabolism.
Curr Opin Clin Nutr Metab Care 4: 521–526.
37. Mittendorfer B, Horowitz JF, Klein S (2002) Effect of gender on lipid kinetics
during endurance exercise of moderate intensity in untrained subjects.
Am J Physiol Endocrinol Metab 283: E58–65.
38. Stanley EG, Bailey NJ, Bollard ME, Haselden JN, Waterfield CJ, et al. (2005)
Sexual dimorphism in urinary metabolite profiles of Han Wistar rats revealed by
nuclear-magnetic-resonance-based metabonomics. Anal Biochem 343: 195–202.
39. Sydora BC, Tavernini MM, Wessler A, Jewell LD, Fedorak RN (2003) Lack of
interleukin-10 leads to intestinal inflammation, independent of the time at which
luminal microbial colonization occurs. Inflamm Bowel Dis 9: 87–97.
40. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W (1993) Interleukin-10-
deficient mice develop chronic enterocolitis. Cell 75: 263–274.
41. Williams HR, Cox IJ, Walker DG, North BV, Patel VM, et al. (2009)
Characterization of inflammatory bowel disease with urinary metabolic
profiling. Am J Gastroenterol 104: 1435–1444.
42. Turner MW (1996) Mannose-binding lectin: the pluripotent molecule of the
innate immune system. Immunol Today 17: 532–540.
43. Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, et al. (2011) Discovery of
sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet 7:
e1002215.
Metabolomic Profiles in IBD
PLOS ONE | www.plosone.org 11 July 2013 | Volume 8 | Issue 7 | e67654
